The latter is the case for CC > TT mutations caused by UV where modifications involving tandem pyrimidines result in 6,4-PPs and CPDs, as seen in TP53 gene assays in vitro and in tandem BRAF mutations in malignant melanomas (Thomas et al., 2004). The gene discussed is BRAF; the disease is melanoma.